Exchange: NASDAQ·Updated 07:35 PM EST

VCYT News

News
all
press releases
Veracyte, Inc. $VCYT Stock Bought by GW&K Investment Management LLC
GW&K Investment Management LLC boosted its position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 70.1% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,409,303 shares of the biotechnology company's stock aft...
MarketBeat
Veracyte, Inc. $VCYT Stock Bought by GW&K Investment Management LLC
GW&K Investment Management LLC boosted its position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 70.1% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,409,303 shares of the biotechnology company's stock aft...
MarketBeat
More News
William Blair Investment Management LLC increased its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 89.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,709,212 shares of the biot...
MarketBeat
Veracyte (VCYT) Securities Investigation Notice - Levi & Korsinsky Veracyte (VCYT) Securities Investigation Notice - Levi & KorsinskyPR NewswireNEW YORK, Nov. 12, 2026 Needham reportedly cut its Veracyte price target by $23 per share after the Company's November 4, 2026 outlook reset on its...
PR Newswire
Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Veracyte, Inc. (Veracyte or the Company) (NASDAQ: VCYT) for violations of the securities laws.INVESTIGATION DETAILS: The investigation focuses on...
Business Wire
VCYT beats Q3 earnings estimates but trims its 2026 revenue outlook as Decipher growth slows and investments in breast and bladder cancer testing rise.
Zacks
VCYT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Veracyte VCYT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving VeracytePR NewswireNEW YORK, Nov. 6, 2026 Veracyte shares fell after its November 4...
PR Newswire
Veracyte Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Veracyte (VCYT) Veracyte Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Veracyte (VCYT)PR NewswireNEW YORK, Nov. 5, 2026 Veracyte stock fell more than 50% after...
PR Newswire
U.S. stocks tumbled: Nasdaq -4.5%, S&P 500 -3.3%, Dow -2.5%. Cardinal Health rose on strong results; AppLovin surged 32%, while Veracyte fell 55%.read more...
Benzinga
Veracyte (VCYT) stock tumbled 54% to a new 52-week low as weaker-than-expected Decipher Prostate test volumes overshadowed Q3 earnings beat.read more...
Benzinga
Veracyte (VCYT) delivered earnings and revenue surprises of +15.91% and +3.06%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.